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ABSTRACT: N-Alkylation of 2-azidobenzenesulfonamide with 5-
bromopent-1-ene gave an N-pentenyl sulfonamide, which under-
went intramolecular aminohydroxylation to give an N-(2-azidoaryl)-
sulfonyl prolinol, a precursor for the synthesis of a pyrrolobenzo-
thiadiazepine. The attempted N-alkylation of 2-azidobenzamide
gave a separable mixture (∼1:1) of a benzotriazinone and a
quinazolinone in a 72% combined yield. Other primary alkyl halides
(3 examples) gave similar mixtures of benzotriazinones and
quinazolinones. Benzylic, allylic, and secondary and tertiary alkyl
halides (5 examples) gave only benzotriazinones in moderate yields.
The results of mechanistic studies show the likely involvement of nitrene intermediates in the quinazolinone pathway and a
second pathway involving a dimethylsulfoxide or dimethylsulﬁde-mediated conversion of 2-azidobenzamide into
benzotriazinones.
■ INTRODUCTION
Pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) 1 are a class of
natural products that have attracted a great deal of interest1
because of their ability to function as sequence-selective DNA-
interactive molecules.2−4 PBD derivatives have entered phase II
clinical trials as antitumor compounds5 and have also attracted
attention as antibiotics with a novel mode of action.6
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) 2 are at-
tracting interest as PBD analogues,7 non-nucleosidic reverse
transcriptase inhibitors,8 antischistosomals,9 and Glut-1 trans-
porter inhibitors (compound 3)10 and are emerging as a
potential treatment for chronic leukemia (compound 4).11−13
Almost all approaches toward the synthesis of PBDs and
PBTDs use L-proline-derived starting materials, meaning that
the de novo synthesis of the pyrrolidine ring is a rare approach
to the PBDs and a very rare approach to the PBTDs.
Metathesis,14 intramolecular lactam formation,15 reductive
cyclization,16,17 cyclization−elimination,18 and ring contraction
of 1,2-thiazines10,19 are approaches to the PBDs that involve
ﬁve-membered ring construction. Only the latter has been
applied for the synthesis of PBTDs. With this in mind, we
became interested in using intramolecular aminohydroxylation
to construct a functionalized pyrrolidine derivative, which
would then act as a precursor to the PBTDs or PBDs.
Intramolecular aminohydroxylation of alkenes is an area of
recent interest in heterocyclic synthesis and has been used to
access simple prolinol derivatives.20−22 Using this, our initial
hypothesis (Figure 1) was that the N-(pent-4-en-1-yl)-
azidobenzenesulfonamide 5 and N-(pent-4-en-1-yl)-
azidobenzamide 6 would undergo aminohydroxylation to
yield N-arylazido-substituted prolinols 7 and 8, respectively,
which could then be used to synthesize PBDs and PBTDs.
■ RESULTS AND DISCUSSION
We synthesized N-(pent-4-en-1-yl)benzenesulfonamide 5 from
the reaction of 2-azidobenzenesulfonamide 9 with 5-bromo-
pentene (21%) or from the reaction of 2-azidobenzenesulfonyl
chloride 10 with pent-4-en-1-amine (63%), as shown in
Scheme 1. Pent-4-en-1-amine was synthesized from 5-
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Figure 1. Initial aim of the current work.
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bromopentene.23 The sulfonyl chloride 10 was synthesized
using diazotization and azidation of 2-aminobenzenesulfonic
acid 11 followed by the treatment of 2-azidobenzenesulfonic
acid 12 with thionyl chloride.10,24 2-Azidobenzenesulfonamide
9 was synthesized by reacting the sulfonyl chloride 10 with
ammonia or from the diazotization and azidation of 2-
aminobenzenesulfonamide 15, which was produced from 2-
nitrobenzenesulfonyl chloride 13 via the sulfonamide 14.10,24
For the intramolecular aminohydroxylation, we found that
Oxone in the presence of tosic acid as an electrophilic oxidant
system, as reported previously by Togo20 for nonazido
substrates, worked well for our azido substrate 5. The desired
prolinol 7 (Scheme 2) was produced over repeated attempts in
an 83−95% yield. As far as we are aware, this is the ﬁrst
reported example of such a reaction having been performed
with an azide group present.
In our previous studies,10,25 we reported the synthesis of the
Glut-1 transporter-inhibiting triazolo-PBTD 3 as a single
enantiomer from the enantiopure version of alcohol 7, which
we derived from L-prolinol. The formation of racemic alcohol 7
gave us the opportunity to provide a sample of racemic 3. Thus,
as shown in Scheme 3, alcohol 7 was oxidized to give aldehyde
16 (96%), which was converted into alkyne 17 using the
Bestmann−Ohira reagent 18. Intramolecular 1,3-dipolar cyclo-
addition occurred spontaneously to furnish the racemic PBTD
derivative 3 in a 70% yield from aldehyde 16.
With a successful PBTD system in hand (Figure 1, X = SO2),
we next attempted to synthesize the analogous PBD system
using the same approach (Figure 1, X = CO). 2-Azidobenzoyl
chloride was prepared in two steps from anthranilic acid26−28
and converted into secondary amide 6 by reaction with pent-4-
en-1-amine.23 Attempted intramolecular aminohydroxylation
failed to deliver the desired N-arylazido substituted 8. As shown
in Scheme 4, we also attempted to form compound 6 by the
reaction of 2-azidobenzamide 20 with 5-bromopentene 19 in
DMSO in the presence of a base, a reaction that had worked
with 2-azidobenzenesulfonamide (Scheme 1). This did not
produce N-(pent-4-en-1-yl)benzamide 6 but instead led to
some unexpected results (also shown in Scheme 4). Thus,
under a variety of conditions, we observed the formation of a
mixture of benzotriazinone 21 and quinazolinone 22. The use
of anhydrous DMSO as the solvent, sodium carbonate as the
base, and a temperature of 95 °C allowed an optimized
combined yield of 72% (isolated yields of 39% for compound
21 and 33% for compound 22) with 4% recovery of the starting
material 20 and the formation of 15% of the reduced product,
2-aminobenzamide 23.
We decided to explore this process in more detail (Scheme
5) with respect to the substrate scope of the organohalide. The
reaction of 2-azidobenzamide with 4-bromobutene gave
benzotriazinone 26 (35%) and quinazolinone 24 (29%),
whereby the expected quinazolinone 25 underwent a facile
double-bond migration to give conjugated 24. The recovered
starting material 20 (8%) and 2-aminobenzamide 23 (14%)
were also present and were also formed in all other reactions
shown in Scheme 5. 1-Bromobutane and 1-bromopropane gave
benzotriazinones 27 and 28, respectively, again as mixtures with
the respective quinazolinones. Benzyl bromide, 2-bromopro-
pane, and bromocyclohexane did not form quinazolinones,
giving only benzotriazinones 29−31, respectively. 2-Bromo-2-
methylpropane behaved unexpectedly and gave benzotriazi-
none 32 in a 30% yield, a reaction that is discussed later. The
identical benzotriazinone 32 was formed in a 36% yield from
the reaction of 2-azidobenzamide with 3-bromo-2-methylprop-
1-ene. Attempts to optimize these reactions further were
unsuccessful: other solvents (see below) did not react; other
bases (Et3N, DBU, DABCO, and pyridine) and/or reduced
temperatures gave reduced yields; and increased temperatures
gave increased degradation resulting in reduced yields of
benzotriazinones and quinazolinones, together with higher
yields of the reduced product 2-aminobenzamide 23.
(Bromomethylene)dibenzene was unreactive toward the azide
but was converted into benzophenone 33, whereas trityl
bromide was unreactive and furnished triphenyl methanol 34.
Scheme 6 shows our suggested mechanism for the formation
of quinazolinones. We consider that nitrene 35 (path A) reacts
Scheme 1. Synthesis of Aminohydroxylation Precursor 5a
aReagents and conditions: (a) NH3 (aq); (b) Pd/C, NH2NH2; (c) (i)
NaNO2, HCl (aq) and (ii) NaN3, NaOAc (aq); (d) 5-bromopentene,
base, and dimethyl sulfoxide (DMSO); (e) (i) NaNO2, HCl (aq) and
(ii) NaN3, NaOAc (aq); (f) SOCl2, reﬂux; (g) pent-4-en-1-amine;
23
and (h) NH3 (aq).
Scheme 2. Intramolecular Aminohydroxylation to Form
PBTD Precursor 7
Scheme 3. Synthesis of Triazolo-PBTD 3
Scheme 4. Formation of Benzotriazinone 21 and
Quinazolinone 22
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with the alkyl halide to form intermediate 36 (path A1), which
undergoes hydrogen radical extrusion to form imine 37.
Cyclization gives the dihydroquinazoline species 38, and loss
of hydrogen would form the ﬁnal quinazolinone. This pathway
also explains the formation of 2-aminobenzamide due to
nitrene 35 abstracting hydrogen from the reaction medium
(path A2). Generation of nitrenes from aryl azides in solvents at
temperatures below 100 °C,29,30 including DMSO,31 is known.
There is an alternative route whereby nitrene formation is
preceded by N-alkylation of the amide nitrogen to give
compound 6 (see earlier for structure and synthesis). However,
we saw no evidence for the formation of compound 6 using
thin-layer chromatography (TLC). Compound 6 also failed to
give quinazolinones under our reaction conditions. Quinazoli-
nones are important and well-known heterocycles32−36 that are
synthesized by a variety of routes including an iron-catalyzed
intramolecular C−N bond formation from N,N-disubstituted 2-
azidobenzamides36 and from dihydroquinazolinones formed
from 2-aminobenzamides and aldehydes using DMSO as a mild
oxidant,37,38 providing some precedent for our suggested
mechanism. We speculated that our process may occur via
the formation of 2-aminobenzamide 23 from the azide and
subsequent reaction with the alkyl halide to give intermediate
39, which could then form species 36. However, when 2-
aminobenzamide was used as the starting material in the place
of 2-azidobenzamide, the reaction was not seen. We also
thought it was possible that DMSO could generate an aldehyde
from the alkyl halide and that this aldehyde was reacting with
either starting material 20 or with 2-aminobenzamide 23 (paths
B and A2b in Scheme 6). We exclude these two paths because
(i) the introduction of the relevant aldehyde into the system
had no inﬂuence and (ii) our reaction was very sensitive to
water (anhydrous DMSO was necessary) and the paths B and
A2b both generate water. Path B also supposes the formation of
an N-acyl imine by the reaction of 2-azidobenzamide with an
aldehyde, a conversion that we have been unable to achieve.
Thus, it appears that 2-azidobenzamide 20 forms nitrene 35
under our reaction conditions and goes on to form
quinazolinones via path A1 and 2-aminobenzamide 23 via
path A2. The secondary amide 6 did not react in this way.
Interestingly, when we subjected a tertiary amide, compound
40 (Scheme 7), to the same reaction conditions, we isolated the
disubstituted dihydroquinazolinone 41, in line with the
literature precedent for tertiary amides.36
Scheme 8 shows our mechanism for the formation of
benzotriazinones 26−32. 3-Substituted 1,2,3-benzotriazin-4-
ones are useful targets in medicinal chemistry39−41 and as
synthetic intermediates.42,43 The most common route to 3-
substituted 1,2,3-benzotriazin-4-ones is diazotization of the
relevant N-substituted anthranilamide.39−42 For our mecha-
nism, we suggest that compound 42 (Scheme 8) is an
intermediate. When this readily available44 compound was used
as the starting material in our reaction, the same benzo-
triazinones could be isolated. N-Alkylation of benzotriazinone
42 is a known route to N-alkyl benzotriazinones.45 2-
Azidobenzamide 20 has an azide group, which can be stabilized
by an intramolecular hydrogen bond that renders the azide
susceptible to nucleophilic attack followed by alkylation. Such
Scheme 5. Reaction of Alkyl Halides with 2-Azidobenzamide
Scheme 6. Mechanisms to Explain Quinazolinone Formation
Scheme 7. Formation of a Dihydroquinazolinone
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processes have precedent in azide chemistry.46−49 Loss of the
azide terminal nitrogen is then facilitated, allowing the
formation of a diazonium species, which can cyclize to give
intermediate 42. As discussed previously, we were able to
isolate signiﬁcant quantities of benzophenone 33 from the
reaction mixture when (bromomethylene)dibenzene was used
as the alkyl halide. We also isolated triphenyl methanol when
trityl bromide was used. DMSO was the only solvent in which
we observed a reaction [dimethylformamide (DMF), nitro-
methane, chloroform, and toluene gave no reaction]. This leads
us to suggest that ketones or aldehydes plus dimethylsulﬁde
form from the known reaction of alkyl halides and DMSO,50
and so, we favor dimethylsulﬁde as the nucleophile, as shown in
Scheme 8. This process consumes 2 equiv of alkyl halide, which
is consistent with our observation that excess alkyl halide is
needed (see Experimental Section). An alternative mechanism
for benzotriazinone formation is for N-alkylation to precede the
nucleophilic attack at the azide, but this would involve N-
alkylation of the amide nitrogen as discussed and dismissed for
the quinazolinone mechanism shown in Scheme 6.
The unexpected formation of benzotriazinone 32 (see
Scheme 5) from 2-bromo-2-methylpropane can be explained
by a combination of the mechanisms shown in Schemes 6 and
8. Thus, as shown in Scheme 9, alkoxysulfonium salt formation
and elimination would generate 2-methylpropene, a process
that has precedent.51,52 The interception of a free radical
species by benzotriazinone 42 would generate the free radical
intermediate 43, which could then react with 2-methylpropene
to form intermediate 44, which would yield benzotriazinone 32
after the loss of a hydrogen radical.
■ CONCLUSIONS
A new approach to the synthesis of pyrrolobenzothiadiazepine
nucleus has been presented that relies upon the formation of a
racemic proline derivative using the previously unreported
intramolecular aminohydroxylation of an N-alkenylated 2-
azidobenzenesulfonamide. We are currently working to expand
the scope of this process by applying it to other N-alkenylated
2-azidobenzenesulfonamide substrates. Attempts to form the
corresponding N-alkenylated 2-azidobenzamides led to mix-
tures of benzotriazinones and benzoquinazolines, which were
formed from an unusual process that allowed us to hypothesize
a nitrene-based pathway to the benzoquinazolines and a
pathway to the benzotriazinones that involves the conversion
of an azide into a diazonium via nucleophilic attack on the
azide. Our work oﬀers some useful and interesting mechanistic
insights into organoazide chemistry and organosulfur chemistry.
■ EXPERIMENTAL SECTION
Compounds (9) to (15)10,24,53 and (20)24,27,28 were
synthesized as described in the literature. The methods that
we used to access racemic (16) and (3) are methods that we
developed previously to produce enantiopure (16) and (3).10,25
Enantiopure compound (7) is also known10,25 but was
previously accessed using chemistry diﬀerent from the new
method that is reported for racemic (7) below. The synthesis of
benzotriazinones (28),54 (29),44 and (30)54 have been reported
previously but with no data and via a diﬀerent route. Other
routes to 2-ethylquinazolin-4(3H)-one,55 2-propylquinazolin-
4(3H)-one,55 and 2-(1′-propen-1′-yl)-quinazolinone (24)56
have been reported.
2-Azido-N-(pent-4-en-1-yl)benzamide (6). 2-Azidoben-
zoic acid (717 mg, 4.4 mmol) was heated at reﬂux in a 2 M
solution of (COCl)2 in dichloromethane (5.0 mL, 10.0 mmol)
with a drop of DMF under an inert atmosphere of nitrogen for
5 h. The reaction was cooled to room temperature before the
crude acid chloride was concentrated, and the residue was
washed with dichloromethane (2 × 20 mL) to give crude 2-
azidobenzoyl chloride as a dark brown solid. One portion of a
solution of potassium carbonate (1.10 g, 8.00 mmol) in water
(10 mL) was added to a stirring solution of 5-amino-1-
pentene23 (170 mg, 2.0 mmol) in dichloromethane (10 mL). 2-
Azidobenzoyl chloride was dissolved in dichloromethane (5
mL) and was added slowly to this solution. The reaction
mixture was stirred at room temperature for 18 h before the
organic layer was separated, and the aqueous layer was washed
with dichloromethane (2 × 20 mL). The combined organic
phases were dried (MgSO4), ﬁltered, concentrated, and puriﬁed
using silica column chromatography (petroleum ether/ethyl
acetate 1:4, Rf = 0.25) to yield the product as a yellow oil (330
mg, 72%). IR (neat, νmax) cm
−1: 1164, 1294, 1445, 1480, 1536,
1577, 1638, 1712, 2125, 2864, 2930, 3076, 3294. 1H NMR (400
MHz, CDCl3): δ 1.66 (2H, tt, J = 7.4, 7.4 Hz,
−CH2CH2CH2−), 2.09 (2H, dt, J = 7.4, 7.8 Hz, CH2CH
CH2), 3.37−3.42 (2H, m, NHCH2), 4.88−4.97 (2H, m, CH
CH2), 5.72−5.82 (1H, m, CHCH2), 7.10 (1H, dd, J1 = 7.8
Hz, J2 = 0.8 Hz, ArH), 7.14 (1H, ddd, J1 = 7.8 Hz, J2 = 7.4 Hz,
J3 = 1.6 Hz, ArH), 7.39−7.41 (2H, m, NH + ArH), 8.04 (1H,
dd, J1 = 7.8 Hz, J2 = 1.6 Hz, ArH). 13C NMR (100 MHz,
CDCl3): δ 28.64 (CH2), 31.25 (CH2), 39.54 (CH2), 115.22
(CH2), 118.37 (CH), 125.17 (CH), 125.26 (qC), 132.17
(CH), 132.19 (CH), 136.82 (qC), 137.79 (CH), 164.58 (C
Scheme 8. Proposed Mechanism for Benzotriazinone
Formation
Scheme 9. Proposed Mechanism to Account for the
Formation of Benzotriazinone 32
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O). HRMS (ESI+) m/z: found 231.1238 [M + H]+,
C12H15N4O requires 231.1240.
2-Azido-N-(pent-4-en-1-yl)benzenesulfonamide (5). 2-
Azido-N-(pent-4-en-1-yl)benzenesulfonamide (5) was formed
in the same manner using 2-azidobenzenesulfonic acid as the
starting material. IR (neat, νmax) cm
−1: 1125, 1162, 1291, 1329,
1415, 1471, 1575, 1641, 2133, 2854, 2926, 3074, 3300. 1H
NMR (400 MHz, CDCl3): δ 1.52 (2H, tt, J = 7.1, 7.1 Hz,
CH2), 2.00 (2H, dt, J = 7.1, 7.1 Hz, CH2), 2.83 (2H, dt, J = 6.8,
6.8 Hz, CH2), 4.88−4.96 (3H, m, N−H, CH2), 5.59−5.70
(1H, m,CH), 7.18−7.23 (2H, m, 2 × ArH), 7.53 (1H, ddd, J
= 7.8, 7.7, 1.3 Hz, ArH), 7.91 (1H, dd, J1 = 7.8 Hz, J2 = 1.1 Hz,
ArH). 13C NMR (100 MHz, CDCl3): δ 28.66 (CH2), 30.67
(CH2), 42.79 (CH2), 115.62 (CH2), 119.36 (CH), 124.91
(CH), 129.92 (qC), 130.76 (CH), 133.96 (CH), 137.19 (CH),
137.47 (qC). HRMS (ESI+) m/z: found 289.0730 [M + Na]+,
C11H14N4O2SNa requires 289.0730.
(1-[(2-Azidophenyl)sulfonyl]pyrrolidin-2-yl)methanol
(7). To a solution of 2-azido-N-(pent-4-en-1-yl)-
benzenesulfonamide (5, 20 mg, 0.075 mmol) and Oxone (35
mg, 0.113 mmol) in a 1:1 mixture (5 mL) of acetonitrile and
water was added p-toluenesulfonic acid monohydrate (2.9 mg,
0.015 mmol). The whole mixture was heated at reﬂux
temperature for 12 h, while being monitored using TLC. To
this solution, saturated aqueous NaHCO3 solution (15 mL)
was added, and the product was extracted with ethyl acetate (3
× 15 mL). The combined organic layer was washed with brine
(15 mL) and dried over anhydrous MgSO4, and the solvent was
removed under vacuum. Puriﬁcation using silica chromatog-
raphy (eluent: petroleum ether/ethyl acetate 1:10, Rf = 0.2)
yielded the product as a yellow oil (20 mg, 95%). IR (neat,
νmax) cm
−1: 1065, 1142, 1200, 1305, 1472, 1575, 1582, 2101,
2872, 2963, 3081, 3526. 1H NMR (400 MHz, CDCl3): δ 1.61−
1.68 (1H, m, CHH), 1.72−1.80 (1H, m, CHH), 1.81−1.98
(2H, m, CH2), 2.70 (1H, bs, CH2OH), 3.28−3.34 (1H, m,
NCH), 3.44−3.50 (1H, m, NCHH), 3.53−3.60 (1H, m,
NCHH), 3.62−3.66 (1H, m, HOCHH), 3.94−4.00 (1H, m,
HOCHH), 7.28 (1H, dd, J1 = 8.1 Hz, J2 = 7.0 Hz, ArH), 7.33
(1H, dd, J = 8.0 Hz, ArH), 7.62 (1H, ddd, J1 = 8.1 Hz, J2 = 7.0
Hz, J3 = 1.1 Hz, ArH), 8.04 (1H, dd, J = 8.0 Hz, J = 1.1 Hz,
ArH). 13C NMR (100 MHz, CDCl3): δ 24.67 (CH2), 29.05
(CH2), 49.52 (CH2), 61.83 (CH), 65.48 (CH2), 119.92 (CH),
124.81 (CH), 129.05 (qC), 132.58 (CH), 134.22 (CH), 138.20
(qC). HRMS (ESI+) m/z: found 305.0674 [M + Na]+,
C11H14N5O3SNa requires 305.0679.
(1-[2-Azidobenzenesulfonyl]pyrrol idin-2-yl ) -
carbaldehyde (16). A 2 M solution of oxalyl chloride in
dichloromethane (0.94 mL, 1.68 mmol) was diluted with
dichloromethane (5 mL) and cooled to −78 °C under nitrogen.
DMSO (0.26 mL, 265 mg, 3.40 mmol) in dichloromethane (5
mL) and alcohol (7) (400 mg, 1.42 mmol) in dichloromethane
(2.5 mL) were added separately, each over 10 min. The whole
mixture was maintained at −78 °C for 30 min before the
dropwise addition of triethylamine (1.09 mL, 0.78 g, 7.09
mmol), and then, it was allowed to reach room temperature.
The reaction was quenched with a mixture of diethyl ether (5
mL) and water (5 mL). The organic layer was separated, and
the aqueous phase was extracted with dichloromethane (3 × 10
mL). The combined organics were dried (MgSO4), ﬁltered,
concentrated, and puriﬁed on silica (20 g) (petroleum ether/
ethyl acetate 3:2, Rf = 0.2) to yield the product as a white solid
(383 mg, 96%, mp = 103−105 °C). IR (neat, νmax) cm−1: 1151,
1323, 1435, 1467, 1572, 1732, 2122, 2887, 2977, 3101. 1H
NMR (400 MHz, CDCl3): δ 1.81−1.95 (2H, m, CH2), 2.00−
2.09 (1H, m, CHH), 2.14−2.23 (1H, m, CHH), 3.38−3.44
(1H, m, NCHH), 3.55−3.60 (1H, m, CHH), 4.46−4.49 (1H,
m, NCH), 7.28 (1H, ddd, J1 = 7.5 Hz, J2 = 7.1 Hz, J3 = 1.5 Hz,
ArH), 7.34 (1H, d, J = 8.0 Hz, ArH), 7.64 (1H, dd, J1 = 7.8 Hz,
J2 = 7.5 Hz, ArH), 8.04 (1H, d, J = 8.0 Hz, ArH), 9.7 (1H, d, J =
9.8 Hz, CHO). 13C NMR (100 MHz, CDCl3): δ 24.99 (CH2),
27.70 (CH2), 48.80 (CH2), 67.08 (CH), 119.88 (CH), 124.86
(CH), 128.97 (qC), 132.50 (CH), 134.38 (CH), 138.24 (qC),
200.42 (CH). HRMS (ESI+) m/z: found 281.0697 [M + H]+,
C11H13N4O3S requires 281.0703.
Pyr ro lo [1 ,2 -b ] [ 1 , 2 , 3 ] t r i a zo lo [5 ,1 -d ] [ 1 , 2 , 5 ] -
benzothiadiazepine 8,8-dioxide (3). Aldehyde (16) (300
mg, 1.07 mmol) was dissolved in dry methanol (5 mL);
potassium carbonate (296 mg, 2.14 mmol) and the Bestmann−
Ohira reagent (209 μL, 247 mg, 1.29 mmol) were added, and
the whole mixture was stirred for 22 h under nitrogen. The
reaction was quenched with saturated aqueous ammonium
chloride (10 mL). The organic phase was separated, and the
aqueous phase was extracted with dichloromethane (3 × 20
mL). The combined organic phases were dried (MgSO4),
ﬁltered, and concentrated in vacuo to yield an orange solid.
Puriﬁcation using silica chromatography (20 g) (petroleum
ether/ethyl acetate 1:3, Rf = 0.22) yielded the product as a
yellow solid (207 mg, 70%, mp = 208−210 °C). IR (neat, νmax)
cm−1: 1050, 1195, 1242, 1336, 1483, 1592, 2870, 2992, 3108.
1H NMR (400 MHz, CDCl3): δ 1.53−1.63 (1H, m, CHH),
1.77−1.85 (1H, m, CHH), 1.87−1.98 (1H, m, CHH), 2.14−
2.21 (1H, m, CHH), 2.98−3.04 (1H, m, CHH), 3.54−3.59
(1H, m, CHH), 5.06−5.10 (1H, m, NCH), 7.51 (1H, dd, J1 =
7.8 Hz, J2 = 7.6 Hz, ArH), 7.67 (1H, s, CHNN), 7.72 (1H, dd,
J1 = 7.8 Hz, J2 = 7.6 Hz, ArH), 7.99 (1H, d, J = 7.8 Hz, ArH),
8.05 (1H, d, J = 7.8 Hz, ArH) ppm. 13C NMR (100 MHz,
DMSO): δ 24.42 (CH2), 35.45 (CH2), 49.96 (CH2), 55.09
(CH), 125.41 (CH), 128.61 (CH), 129.32 (CH), 130.94 (qC),
133.54 (qC), 134.03 (CH), 134.37 (CH), 136.77 (qC) ppm.
HRMS (ESI+) m/z: found 277.0754 [M + H]+, C12H13N4O2S
requires 277.0754.
3-(Pent-4-en-1-yl)benzo[d][1,2,3]triazin-4-one (22)
and 2-(But-3-en-1-yl)quinazolin-4-one (21). To a solution
of 2-azidobenzamide (200 mg, 1.23 mmol) and sodium
carbonate (392 mg, 3.70 mmol) in anhydrous DMSO (10
mL), 5-bromo-1-pentene (368 mg, 2.46 mmol) was added. The
solution was heated at 95 °C for 48 h under a nitrogen
atmosphere, and after the completion of the reaction, which
was monitored using TLC, the resultant mixture was diluted
with dichloromethane (30 mL) and washed with 0.1 M NaCl
and water many times to remove DMSO. The mixture was
dried with anhydrous magnesium sulfate and ﬁltered under
gravity, and the solvent was removed under vacuum. The
residue was puriﬁed using column chromatography to give 3-
(pent-4-en-1-yl)benzo[d][1,2,3]triazin-4-one (22) (eluent: pe-
troleum ether/ethyl acetate 4:1, Rf = 0.2) as a dark orange oil
(100 mg, 38%). IR (neat, νmax) cm
−1: 1037, 1072, 1184, 1274,
1333, 1463, 1579, 1607, 1641, 1680, 2856, 2929, 3076. 1H
NMR (400 MHz, CDCl3): δ 1.90−1.96 (2H, m, CH2), 2.10−
2.20 (2H, m, CH2), 4.41 (2H, t, J = 7.3 Hz, CH2), 4.92 (1H, d,
J = 10.2 Hz, CHH), 5.00 (1H, d, J = 17.1 Hz, CHH), 5.71−
5.82 (1H, m, CH), 7.72 (1H, dd, J1 = 7.7 Hz, J2 = 7.5 Hz, ArH),
7.86 (1H, dd, J1 = 7.7 Hz, J2 = 7.3 Hz, ArH), 8.07 (1H, d, J =
7.7 Hz, ArH), 8.27 (1H, d, J = 7.7 Hz, ArH). 13C NMR (100
MHz, CDCl3): δ 27.90 (CH2), 30.72 (CH2), 49.37 (CH2),
115.56 (CH2), 119.77 (qC), 125.01 (CH), 128.18 (CH),
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132.23 (CH), 134.69 (CH), 137.12 (CH), 144.27 (qC), 155.46
(CO). HRMS (ESI+) m/z: found 215.1059 [M]+,
C12H13N3O requires 215.1059. Also isolated was 2-(but-3-en-
1-yl)quinazolin-4-one (21) (eluent: petroleum ether/ethyl
acetate 1:1, Rf = 0.3) as a light yellow solid (80 mg, 33%,
mp: 167−169 °C). IR (neat, νmax) cm−1: 1105, 1140, 1195,
1253, 1288, 1342, 1421, 1445, 1469, 1564, 1609, 1673, 2916,
2975, 3030, 3168. 1H NMR (400 MHz, CDCl3): δ 2.59 (2H,
m, CH2), 2.84 (2H, t, J = 7.3 Hz, CH2), 4.97 (1H, d, J = 10.1
Hz, CHH), 5.08 (1H, dd, J1 = 17.1 Hz, J2 = 1.0 Hz, 
CHH), 5.82−5.92 (1H, m, CH), 7.40 (1H, dd, J1 = 7.8 Hz, J2 =
7.2 Hz, ArH), 7.63 (1H, d, J = 8.0 Hz, ArH), 7.70 (1H, dd, J1 =
8.0 Hz, J2 = 7.1 Hz, ArH), 8.21 (1H, d, J = 7.8 Hz, ArH), 12.11
(1H, bs, NH). 13C NMR (100 MHz, CDCl3): δ 31.31 (CH2),
35.19 (CH2), 116.29 (CH2), 120.53 (qC), 126.24 (CH),
126.44 (CH), 127.26 (CH), 134.82 (CH), 136.43 (CH),
149.45 (qC), 156.07 (qC), 164.39 (CO) ppm. HRMS
(ESI+) m/z: found 201.1023 [M + H]+, C12H13N2O requires
201.1022.
3-(But-3-en-1-yl)benzo[d][1,2,3]triazin-4-one (26) and
2-(1′-Propen-1′-yl)-quinazolinone (24). To a solution of 2-
azidobenzamide (200 mg, 1.23 mmol) and sodium carbonate
(392 mg, 3.70 mmol) in anhydrous DMSO (10 mL), 4-bromo-
1-butene (333 mg, 2.47 mmol) was added. The solution was
heated at 95 °C for 48 h under a nitrogen atmosphere, and after
completion of the reaction, which was monitored using TLC,
the resultant mixture was diluted with dichloromethane (30
mL) and washed with 0.1 M NaCl and water many times to
remove DMSO. The mixture was dried with anhydrous
magnesium sulfate and ﬁltered under gravity, and the solvent
was removed under vacuum. The residue was puriﬁed using
column chromatography to give 3-(but-3-en-1-yl)benzo[d]-
[1,2,3]triazin-4-one (26) (eluent: petroleum ether/ethyl
acetate 4:1, Rf = 0.21) as a yellow oil (85 mg, 35%). IR
(neat, νmax) cm
−1: 1043, 1105, 1165, 1280, 1296, 1346, 1463,
1608, 1642, 1681, 2840, 2954, 3075. 1H NMR (400 MHz,
CDCl3): δ 2.61 (2H, dt, J = 7.1, 7.1 Hz, CH2), 4.47 (2H, t, J =
7.1 Hz, CH2), 4.95−5.05 (2H, m,CH2), 5.71−5.84 (1H, m,CH), 7.72 (1H, dd, J1 = 7.7 Hz, J2 = 7.4 Hz, ArH), 7.86 (1H,
dd, J1 = 8.1 Hz, J2 = 8.0 Hz, ArH), 8.06 (1H, d, J = 8.1 Hz,
ArH), 8.27 (1H, d, J = 7.7 Hz, ArH). 13C NMR (100 MHz,
CDCl3): δ 33.15 (CH2), 49.03 (CH2), 117.78 (CH2), 119.77
(qC), 125.07 (CH), 128.24 (CH), 132.27 (CH), 133.97 (CH),
134.73 (CH), 144.27 (qC), 155.50 (CO) ppm. HRMS
(ESI+) m/z: found 202.0970 [M + H]+, C11H12N3O requires
202.0975. Also isolated was 2-(1′-propen-1′-yl)-quinazolinone
(24) (eluent: petroleum ether/ethyl acetate 1:1, Rf = 0.29) as a
yellow solid (65 mg, 29%, mp = 148−150 °C). IR (neat, νmax)
cm−1: 1007, 1144, 1252, 1296, 1343, 1468, 1562, 1607, 1659,
2924, 3063, 3182. 1H NMR (400 MHz, CDCl3): δ 2.08 (3H,
dd, J1 = 6.8 Hz, J2 = 1.1 Hz, CH3), 6.40 (1H, dd, J
1 = 15.9 Hz, J2
= 1.3 Hz,CH), 7.19−7.26 (1H, m,CH), 7.47 (1H, dd, J1
= 7.6 Hz, J2 = 7.3 Hz, ArH), 7.72 (1H, d, J = 7.8 Hz, ArH), 7.78
(1H, dd, J1 = 7.8 Hz, J2 = 7.6 Hz, ArH), 8.30 (1H, d, J = 7.6 Hz,
ArH), 11.98 (1H, s, NH). 13C NMR (100 MHz, CDCl3): δ
18.77 (CH3), 120.75 (qC), 125.32 (CH), 126.28 (CH), 126.36
(CH), 127.51 (CH), 134.83 (CH), 138.47 (CH), 149.67 (qC),
150.89 (qC), 164.12 (CO). HRMS (ESI+) m/z: found
187.0860 [M + H]+, C11H11N3O requires 187.0793. The data
recorded for compound (24) are consistent with those
published elsewhere.56
3-Butylbenzo[d][1,2,3]triazin-4(3H)-one (27) and 2-
Propylquinazolin-4(3H)-one. To a solution of 2-azidobenza-
mide (200 mg, 1.23 mmol) and sodium carbonate (392 mg,
3.70 mmol) in anhydrous DMSO (10 mL), 1-bromobutane
(338 mg, 2.47 mmol) was added. The solution was heated at 95
°C for 48 h under a nitrogen atmosphere, and after completion
of the reaction, which was monitored using TLC, the resultant
mixture was diluted with dichloromethane (30 mL) and washed
with 0.1 M NaCl and water many times to remove DMSO. The
mixture was dried with anhydrous magnesium sulfate and
ﬁltered under gravity, and the solvent was removed under
vacuum. The residue was puriﬁed using column chromatog-
raphy to give 3-butylbenzo[d][1,2,3]triazin-4(3H)-one (27)
(eluent: petroleum ether/ethyl acetate 4:1, Rf = 0.2) as a light
yellow oil (92 mg, 37%). IR (neat, νmax) cm
−1: 1032, 1164,
1294, 1320, 1380, 1429, 1463, 1607, 1678, 2873, 2960. 1H
NMR (400 MHz, CDCl3): δ 0.91 (3H, t, J = 7.4 Hz, CH3),
1.37 (2H, app. sextet, J = 7.6 Hz, CH2), 1.86 (2H, app. pentet, J
= 7.5 Hz, CH2), 4.40 (2H, t, J = 7.1 Hz, CH2), 7.71 (1H, dd, J
1
= 7.9 Hz, J2 = 7.5 Hz, ArH), 7.86 (1H, dd, J1 = 7.9 Hz, J2 = 7.5
Hz, ArH), 8.07 (1H, d, J = 8.1 Hz, ArH), 8.28 (1H, d, J = 8.1
Hz, ArH). 13C NMR (100 MHz, CDCl3): δ 13.66 (CH3), 19.89
(CH2), 30.94 (CH2), 49.67 (CH2), 119.83 (qC), 125.05 (CH),
128.18 (CH), 132.20 (CH), 134.66 (CH), 144.33 (qC), 155.50
(CO). HRMS (ESI+) m/z: found 204.1127 [M + H]+,
C11H14N3O requires 204.1131. Also formed was 2-propylqui-
nazolin-4(3H)-one (eluent: petroleum ether/ethyl acetate 1:1,
Rf = 0.22) as a light yellow oil (∼20% by NMR), which could
not be obtained free of 2-aminobenzamide. IR (neat, νmax)
cm−1: 1082, 1161, 1265, 1293, 1394, 1449, 1478, 1565, 1615,
1650, 2962, 3173. 1H NMR (400 MHz, CDCl3): δ 0.98 (3H, t,
J = 7.5 Hz, CH3), 1.69 (2H, app. sextet, J = 7.4 Hz, CH2), 2.68
(2H, t, J = 7.8 Hz, CH2), 7.37 (1H, dd, J
1 = 8.0 Hz, J2 = 7.0 Hz,
HAr), 7.61 (1H, d, J = 8.0 Hz, HAr), 7.68 (1H, dd, J1 = 8.0 Hz,
J2 = 7.0 Hz, HAr), 8.17 (1H, d, J = 8.0 Hz, HAr), 11.12 (1H, s,
NH). 13C NMR (100 MHz, CDCl3): δ 13.77 (CH3), 18.99
(CH2), 40.47 (CH2), 121.46 (qC), 122.46 (CH), 125.18 (CH),
127.35 (CH), 132.96 (CH), 149.47 (qC), 157.17 (qC), 164.25
(CO). HRMS (ESI+) m/z: found 189.1023 [M + H]+,
C11H13N2O requires 189.1022. The data recorded for 2-
propylquinazolin-4(3H)-one are consistent with those pub-
lished elsewhere.55
3-Propylbenzo[d][1,2,3]triazin-4-one (28) and 2-Ethyl-
quinazolin-4-one. To a solution of 2-azidobenzamide (200
mg, 1.23 mmol) and sodium carbonate (392 mg, 3.70 mmol) in
anhydrous DMSO (10 mL), 1-bromo propane (304 mg, 2.47
mmol) was added. The solution was heated at 95 °C for 48 h
under a nitrogen atmosphere, and after completion of the
reaction, which was monitored using TLC, the resultant
mixture was diluted with dichloromethane (30 mL) and
washed with 0.1 M NaCl and water many times to remove
DMSO. The mixture was dried with anhydrous magnesium
sulfate and ﬁltered under gravity, and the solvent was removed
under vacuum. The residue was puriﬁed using column
chromatography to give 3-propylbenzo[d][1,2,3]triazin-4-one
(28) (eluent: petroleum ether/ethyl acetate 4:1, Rf = 0.21) as a
light yellow solid (88 mg, 38%, mp = 49−51 °C). IR (neat,
νmax) cm
−1: 1024, 1143, 1175, 1226, 1281, 1294, 1320, 1334,
1458, 1497, 1578, 1606, 1641, 2879, 2964. 1H NMR (400
MHz, CDCl3): δ 0.95 (3H, t, J = 7.4 Hz, CH3), 1.88 (2H, app.
sextet, J = 7.4 Hz, CH2), 4.37 (2H, t, J = 7.4 Hz, CH2), 7.72
(1H, dd, J1 = 7.9 Hz, J2 = 7.3 Hz, ArH), 7.87 (1H, dd, J1 = 8.1
Hz, J2 = 7.5 Hz, ArH), 8.07 (1H, d, J = 8.1 Hz, ArH), 8.29 (1H,
d, J = 7.9 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ 11.18
(CH3), 22.29 (CH2), 51.44 (CH2), 119.85 (qC), 125.08 (CH),
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128.20 (CH), 132.21 (CH), 134.68 (CH), 144.33 (qC), 155.54
(CO). HRMS (ESI+) m/z: found 190.0973 [M + H]+,
C10H12N3O requires 190.0975. Also present was 2-ethyl-
quinazolin-4-one (eluent: petroleum ether/ethyl acetate 1:1,
Rf = 0.28) as a light yellow solid (∼23% by NMR), which could
not be obtained free of 2-aminobenzamide. IR (neat, νmax)
cm−1: 1139, 1201, 1251, 1341, 1373, 1467, 1504, 1608, 1619,
1674, 2853, 2922, 3044, 3163. 1H NMR (400 MHz, CDCl3): δ
1.17−1.38 (2H, m, CH3), 2.78 (2H, d, J = 6.9 Hz, CH2), 7.18
(1H, bs, ArH), 7.38−7.40 (1H, m, ArH), 7.64−7.68 (2H, m, 2
× ArH), 8.22 (1H, d, J = 6.8 Hz, ArH), 12.17 (1H, s, NH). 13C
NMR (100 MHz, CDCl3): δ 11.57 (CH3), 29.71 (CH2),
120.50 (qC), 126.23 (CH), 126.33 (CH), 127.22 (CH), 134.78
(CH), 149.54 (qC), 156.78 (qC), 164.57 (CO). HRMS
(ESI+) m/z: found 175.0869 [M + H]+, C10H11N2O requires
175.0866. The data recorded for 2-ethylquinazolin-4(3H)-one
are consistent with those published elsewhere.55
3-Benzylbenzo[d][1,2,3]triazin-4-one (29). To a solution
of 2-azidobenzamide (200 mg, 1.23 mmol) and sodium
carbonate (392 mg, 3.70 mmol) in anhydrous DMSO (10
mL), benzyl bromide (422 mg, 2.47 mmol) was added. The
solution was heated at 95 °C for 48 h under a nitrogen
atmosphere, and after completion of the reaction, which was
monitored using TLC, the resultant mixture was diluted with
dichloromethane (30 mL) and washed with 0.1 M NaCl and
water many times to remove DMSO. The mixture was dried
with anhydrous magnesium sulfate and ﬁltered under gravity,
and the solvent was removed under vacuum. The residue was
puriﬁed using column chromatography (eluent: petroleum
ether/ethyl acetate 4:1, Rf = 0.2) to yield the product as a
yellow solid (95 mg, 33%, mp = 110−112 °C; lit.39 114−116
°C). IR (neat, νmax) cm
−1: 1049, 1086, 1179, 1205, 1295, 1349,
1454, 1492, 1581, 1605, 1682, 3033. 1H NMR (400 MHz,
CDCl3): δ 5.65 (2H, s, CH2), 7.29−7.38 (3H, m, 3 × ArH),
7.55 (2H, d, J = 6.9 Hz, 2 × ArH), 7.79 (1H, dd, J1 = 7.7 Hz, J2
= 7.3 Hz, ArH), 7.94 (1H, dd, J1 = 8.0 Hz, J2 = 7.3 Hz, ArH),
8.16 (1H, d, J = 8.0 Hz, ArH), 8.35 (1H, d, J = 7.7 Hz, ArH)
ppm. 13C NMR (100 MHz, CDCl3): δ 53.39 (CH2), 120.10
(qC), 125.18 (qC), 128.23 (CH), 128.33 (CH), 128.73 (2 ×
CH), 128.87 (2 × CH), 132.36 (CH), 134.82 (CH), 135.76
(qC), 144.34 (qC), 155.39 (CO) ppm. HRMS (ESI+) m/z:
found 238.0977 [M + H]+, C14H12N3O requires 238.0975.
3-Isopropylbenzo[d][1,2,3]triazin-4-one (30). To a
solution of 2-azidobenzamide (200 mg, 1.23 mmol) and
sodium carbonate (392 mg, 3.70 mmol) in anhydrous DMSO
(10 mL), 2-bromopropane (301 mg, 2.47 mmol) was added.
The solution was heated at 95 °C for 48 h under a nitrogen
atmosphere, and after completion of the reaction, which was
monitored using TLC, the resultant mixture was diluted with
dichloromethane (30 mL) and washed with 0.1 M NaCl and
water many times to remove DMSO. The mixture was dried
with anhydrous magnesium sulfate and ﬁltered under gravity,
and the solvent was removed under vacuum. The residue was
puriﬁed using column chromatography (eluent: petroleum
ether/ethyl acetate 4:1, Rf = 0.23) to yield the product as a light
yellow solid (80 mg, 34%, mp = 47−49 °C). IR (neat, νmax)
cm−1: 1016, 1131, 1195, 1266, 1290, 1338, 1386, 1462, 1494,
1608, 1677, 2875, 2976. 1H NMR (400 MHz, CDCl3): δ 1.60
(6H, d, J = 6.8 Hz, 2 × CH3), 5.45 (1H, sept., J = 6.8 Hz, CH),
7.79 (1H, dd, J1 = 7.8 Hz, J2 = 7.5 Hz, ArH), 7.94 (1H, dd, J1 =
7.8 Hz, J2 = 7.5 Hz, ArH), 8.15 (1H, d, J = 8.1 Hz, ArH), 8.36
(1H, d, J = 8.1 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ
21.61 (2 × CH3), 49.53 (CH), 119.61 (qC), 125.20 (CH),
128.05 (CH), 132.07 (CH), 134.66 (CH), 144.00 (qC), 155.09
(CO). HRMS (ESI+) m/z: found 190.0970 [M + H]+,
C10H12N3O requires 190.0975.
3-Cyclohexylbenzo[d][1,2,3]triazin-4-one (31). To a
solution of 2-azidobenzamide (200 mg, 1.23 mmol) and
sodium carbonate (392 mg, 3.70 mmol) in anhydrous DMSO
(10 mL), bromocyclohexane (403 mg, 2.47 mmol) was added.
The solution was heated at 95 °C for 48 h under a nitrogen
atmosphere, and after completion of the reaction, which was
monitored using TLC, the resultant mixture was diluted with
dichloromethane (30 mL) and washed with 0.1 M NaCl and
water many times to remove DMSO. The mixture was dried
with anhydrous magnesium sulfate and ﬁltered under gravity,
and the solvent was removed under vacuum. The residue was
puriﬁed using column chromatography (eluent: petroleum
ether/ethyl acetate 4:1, Rf = 0.23) to yield the product as a light
yellow solid (85 mg, 30%, mp = 137−139 °C). IR (neat, νmax)
cm−1: 1064, 1164, 1161, 1181, 1221, 1267, 1292, 1331, 1376,
1460, 1607, 1681, 2851, 2928, 3073. 1H NMR (400 MHz,
CDCl3): δ 1.17−1.30 (1H, m, CHH), 1.39−1.50 (2H, m,
CH2), 1.68−2.72 (1H, m, CHH), 1.86−2.01 (6H, m, 3 ×
CH2), 4.96 (1H, p, J = 7.6 Hz, CH), 7.70 (1H, dd, J
1 = 8.0 Hz,
J2 = 7.3 Hz, ArH), 7.85 (1H, ddd, J1 = 8.1 Hz, J2 = 8.0 Hz, J3 =
1.1 Hz, ArH), 8.06 (1H, d, J = 8.0 Hz, ArH), 8.28 (1H, d, J =
8.1 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ 25.31 (CH2),
25.80 (2 × CH2), 56.64 (2 × CH2), 119.60 (qC), 123.01 (qC),
125.27 (CH), 128.02 (CH), 132.00 (CH), 134.62 (CH),
143.88 (qC), 155.12 (CO). HRMS (ESI+) m/z: found
230.1285 [M + H]+, C13H16N3O requires 230.1288.
3-(2-Methylallyl)benzo[d][1,2,3]triazin-4-one (32). To
a solution of 2-azidobenzamide (200 mg, 1.23 mmol) and
sodium carbonate (392 mg, 3.70 mmol) in anhydrous DMSO
(10 mL), 3-bromo-2-methylpropene (333 mg, 2.47 mmol) was
added. The solution was heated at 95 °C for 48 h under a
nitrogen atmosphere, and after completion of the reaction,
which was monitored using TLC, the resultant mixture was
diluted with dichloromethane (30 mL) and washed with 0.1 M
NaCl and water many times to remove DMSO. The mixture
was dried with anhydrous magnesium sulfate and ﬁltered under
gravity, and the solvent was removed under vacuum. The
residue was puriﬁed using column chromatography (eluent:
petroleum ether/ethyl acetate 4:1, Rf = 0.21) to yield the
product as a light orange solid (90 mg, 36%, mp = 69−71 °C).
IR (neat, νmax) cm
−1: 1089, 1153, 1223, 1276, 1297, 1333,
1463, 1580, 1609, 1684, 2930, 2973, 3083. 1H NMR (400
MHz, CDCl3): δ 1.84 (3H, s, CH3), 4.85 (1H, s, CHH),
5.00 (H, s,CHH), 5.03 (2H, s, CH2), 7.83 (1H, ddd, J1 = 8.1
Hz, J2 = 8.0 Hz, J3 = 1.1 Hz, ArH), 7.97 (1H, ddd, J1 = 8.1 Hz,
J2 = 8.0 Hz, J3 = 1.1 Hz, ArH), 8.18 (1H, d, J = 8.1 Hz, ArH),
8.38 (1H, dd, J1 = 8.1 Hz, J2 = 1.0 Hz, ArH). 13C NMR (100
MHz, CDCl3): δ 20.45 (CH3), 54.77 (CH2), 113.54 (CH2),
119.88 (qC), 125.22 (CH), 128.33 (CH), 132.38 (CH), 134.84
(CH), 139.51 (qC), 144.29 (qC), 155.43 (CO). HRMS
(ESI+) m/z: found 202.0975 [M + H]+, C11H12N3O requires
202.0975.
3-(2-Methylallyl)benzo[d][1,2,3]triazin-4-one (32):
Method 2from 2-Bromo-2-methylpropane. To a
solution of 2-azidobenzamide (250 mg, 1.54 mmol) and
sodium carbonate (490 mg, 4.63 mmol) in anhydrous DMSO
(15 mL), 2-bromo-2-methylpropane (425 mg, 3.10 mmol) was
added. The solution was heated at 95 °C for 45 h under a
nitrogen atmosphere, and the resultant mixture was diluted
with dichloromethane (50 mL) and washed with 0.1 M NaCl
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and water many times to remove DMSO. The mixture was
dried with anhydrous magnesium sulfate and ﬁltered under
gravity, and the solvent was removed under vacuum. The
residue was puriﬁed using column chromatography (eluent:
petroleum ether/ethyl acetate 4:1, Rf = 0.21) to yield the
product as a light yellow oil (94 mg, 30%) with identical
spectroscopic data to those reported above.
2-Azido-N,N-dibutylbenzamide (40). 2-Azidobenzamide
(98 mg, 0.60 mmol), KOH (50 mg, 0.90 mmol), and TBAB
(58 mg, 0.18 mmol) were mixed and stirred for 15 min at room
temperature, and then, 1-bromobutane (102 mg, 81 μL, 0.75
mmol) was added. The mixture was heated at 80 °C in an oil
bath for 15 min. The crude mixture was diluted with water (10
mL) and then extracted with dichloromethane (3 × 10 mL).
The organic layer was dried with anhydrous magnesium sulfate
and ﬁltered, and the solvent was removed in vacuo. Puriﬁcation
using silica chromatography (eluent: petroleum ether/ethyl
acetate 2:1, Rf = 0.25) yielded the product as a yellow oil (115
mg, 70%). IR (neat, νmax) cm
−1: 1081, 1118, 1201, 1289, 1425,
1444, 1577, 1598, 1633, 2091, 2873, 2931, 2957. 1H NMR (400
MHz, CDCl3): δ 0.68 (3H, t, J = 7.3 Hz, CH3), 0.90 (3H, t, J =
7.3 Hz, CH3), 1.04 (2H, app. Sextet, J = 7.3 Hz, CH2), 1.29−
1.38 (4H, m, 2 × CH2), 1.57 (2H, app. Pentet, J = 7.6 Hz,
CH2), 2.96−2.98 (2H, m, CH2), 3.29 (1H, br s, CHH), 3.54
(1H, br s, CHH), 7.06−7.14 (3H, m, 3 × ArH), 7.31 (1H, ddd,
J1 = 8.2 Hz, J2 = 8.0 Hz, J3 = 1.4 Hz, ArH). 13C NMR (100
MHz, CDCl3): δ 13.56 (CH3), 13.93 (CH3), 19.70 (CH2),
20.25 (CH2), 29.51 (CH2), 30.55 (CH2), 44.22 (CH2), 48.18
(CH2), 118.41 (CH), 124.93 (CH), 127.87 (CH), 129.44
(qC), 129.95 (CH), 136.17 (qC), 168.19 (CO). HRMS
(ESI+) m/z: found 275.1860 [M + H]+, C15H23N4O requires
275.1866.
3-Butyl-2-propyl-2,3-dihydroquinazolin-4-one (41).
To a solution of 2-azido-N,N-dibutylbenzamide (98 mg, 0.36
mmol) and sodium carbonate (114 mg, 1.07 mmol) in
anhydrous DMSO (8 mL), 2-bromopropane (88 mg, 67 μL,
0.72 mmol) was added. The solution was heated at 95 °C for
48 h under a nitrogen atmosphere, and after completion of the
reaction, which was monitored using TLC, there was no
product. The reaction mixture was heated at 120 °C for 48 h,
and after completion of the reaction, which was monitored
using TLC, the resultant mixture was diluted with dichloro-
methane (30 mL) and washed with 0.1 M NaCl and water
many times to remove DMSO. The mixture was dried with
anhydrous magnesium sulfate and ﬁltered under gravity, and
the solvent was removed under vacuum. The residue was
puriﬁed using column chromatography (eluent: petroleum
ether/ethyl acetate 2:1, Rf = 0.21) to yield the product as a
yellow oil (55 mg, 63%). IR (neat, νmax) cm
−1: 1028, 1153,
1169, 1322, 1464, 1509, 1580, 1610, 2872, 2930, 2957, 3284.
1H NMR (400 MHz, CDCl3): δ 0.84 (6H, 2 × t, J = 7.2 Hz, 2
× CH3), 1.15−1.24 (1H, m, CHH), 1.29−1.36 (3H, m, CH2 +
CHH), 1.50−1.59 (3H, m, CH2 + CHH), 1.74−1.84 (1H, m,
CHH), 2.76 (1H, dt, J = 13.7, 7.1 Hz, NCHH), 4.04 (1H, dt, J
= 13.7, 7.5 Hz, NCHH), 4.48−4.50 (2H, m, CH + NH), 6.55
(1H, d, J = 8.0 Hz, ArH), 6.75 (1H, ddd, J1 = 7.8 Hz, J2 = 7.6
Hz, J3 = 1.2 Hz, ArH), 7.16−7.20 (1H, m, ArH), 7.81 (1H, dd,
J1 = 7.8 Hz, J2 = 1.2 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ
13.68 (CH3), 13.89 (CH3), 18.64 (CH2), 20.15 (CH2), 30.48
(CH2), 35.48 (CH2), 44.88 (CH2), 69.25 (CH), 114.81 (CH),
117.14 (qC), 118.41 (CH), 128.41 (CH), 133.06 (CH), 145.06
(qC), 162.34 (CO). HRMS (ESI+) m/z: found 247.1802 [M
+ H]+, C13H16N3O requires 247.1805.
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Khan, M. N.; Patel, N.; Airley, R.; Day, S. Azide based routes to
tetrazolo and oxadiazolo derivatives of pyrrolobenzodiazepines and
pyrrolobenzothiadiazepines. Tetrahedron 2014, 70, 7306.
ACS Omega Article
DOI: 10.1021/acsomega.7b00211
ACS Omega 2017, 2, 1222−1231
1229
(11) Di Stefano, C.; Marfe, G.; Trawinska, M. M.; Sinibaldi-Salimei,
P.; Silvestri, R.; Amadori, S.; Abruzzese, E. Pyrrolo[1,2-b][1,2,5]-
benzothiadiazepines (PBTDs) exert their anti-proliferative activity by
interfering with Akt-mTOR signaling and bax:bcl-2 ratio modulation
in cells from chronic myeloid leukemic patients. Cancer Sci. 2010, 101,
991.
(12) Silvestri, R.; Marfe,̀ G.; Artico, M.; La Regina, G.; Lavecchia, A.;
Novellino, E.; Morgante, M.; Di Stefano, C.; Catalano, G.; Filomeni,
G.; Abruzzese, E.; Ciriolo, M. R.; Russo, M. A.; Amadori, S.; Cirilli, R.;
La Torre, F.; Salimei, P. S. Pyrrolo[1,2-b][1,2,5]benzothiadiazepines
(PBTDs): A New Class of Agents with High Apoptotic Activity in
Chronic Myelogenous Leukemia K562 Cells and in Cells from
Patients at Onset and Who Were Imatinib-Resistant. J. Med. Chem.
2006, 49, 5840.
(13) Maffei, G.; Mirone, G.; Perna, S.; Di Stefano, C. The Effects of
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines in MEC1 Cells. J. Cell.
Biochem. 2015, 116, 339.
(14) Kitamura, T.; Sato, Y.; Mori, M. Synthetic study of
(+)-anthramycin using ring-closing enyne metathesis and cross-
metathesis. Tetrahedron 2004, 60, 9649.
(15) Roos, G. H. P.; Dastlik, K. A. Approach to the Synthesis of
(+)-Ifforestine. Model Studies Directed at the Tetracyclic Framework.
Heterocycles 2003, 60, 2023.
(16) Miyamoto, M.; Kondo, S.; Naganawa, H.; Maeda, K.; Ohno, M.;
Umezawa, H. Structure and synthesis of neothramycin. J. Antibiot.
1977, 30, 340.
(17) Fukuyama, T.; Lin, S. C.; Li, L. Facile reduction of ethyl thiol
esters to aldehydes: Application to a total synthesis of (+)-neo-
thramycin A methyl ether. J. Am. Chem. Soc. 1990, 112, 7050.
(18) Fukuyama, T.; Liu, G.; Linton, S. D.; Lin, S.-C.; Nishino, H.
Total synthesis of (+)-porothramycin B. Tetrahedron Lett. 1993, 34,
2577.
(19) Hemming, K.; Patel, N. The Synthesis of Pyrrolo[1,2-
b][1,2,5]benzothiadiazepines from 1,2-Thiazine 1-oxidesSulfona-
mide Analogues of the Pyrrolobenzodiazepine Antitumour Natural
Products. Tetrahedron Lett. 2004, 45, 7553.
(20) Moriyama, K.; Izumisawa, Y.; Togo, H. Brønsted Acid-Assisted
Intramolecular Aminohydroxylation of N-Alkenylsulfonamides under
Heavy Metal-Free Conditions. J. Org. Chem. 2012, 77, 9846.
(21) Liu, G.-Q.; Li, L.; Duan, L.; Li, Y.-M. mCPBA-mediated metal-
free intramolecular aminohydroxylation and dioxygenation of un-
functionalized olefins. RSC Adv. 2015, 5, 61137.
(22) Yin, Y.; Zhou, H.; Sun, G.; Liu, X. m-CPBA-Mediated
Intramolecular Aminohydroxylation of N-Sulfonyl Aminoalkenes to
Synthesize β-Hydroxyl Cyclic Amines. J. Heterocycl. Chem. 2015, 52,
1337.
(23) Gagne, M. R.; Stern, C. L.; Marks, T. J. Organolanthanide-
catalyzed hydroamination. A kinetic, mechanistic, and diastereoselec-
tivity study of the cyclization of N-unprotected amino olefins. J. Am.
Chem. Soc. 1992, 114, 275.
(24) Blackburn, C.; Achab, A.; Elder, A.; Ghosh, S.; Guo, J.;
Harriman, G.; Jones, M. Synthesis of 3-Amino-1,2,4-benzothiadi-azine
1,1-Dioxides via a Tandem Aza-Wittig/Heterocumulene Annulation. J.
Org. Chem. 2005, 70, 10206.
(25) Chambers, C. S.; Patel, N.; Hemming, K. Intramolecular 1,3-
dipolar cycloaddition as a route to triazolobenzodiazepines and
pyrrolobenzodiazepines. Tetrahedron Lett. 2010, 51, 4859.
(26) Hemming, K.; Chambers, C.; Jamshaid, F.; O’Gorman, P.
Intramolecular azide to alkene cycloadditions for the construction of
pyrrolobenzodiazepines and azetidino-benzodiazepines. Molecules
2014, 19, 16737.
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